San Jose, CA, United States of America

Nicholas Michael Sampas

This inventor holds 41 USPTO granted patents and 13 published patent applications and 3 EPO patents, primarily in Nucleic Acid Analysis. Top assignees: Agilent Technologies, Inc., Hewlett-Packard Company, Alverix, Inc.. Active years: 1996-2025.

USPTO Granted Patents = 41 

% Patents Active = 82.9

 

Average Co-Inventor Count = 2.5

ph-index = 17

Forward Citations = 1,232(Granted Patents)


Location History:

  • Menlo Park, CA (US) (1996 - 1998)
  • San Francisco, CA (US) (2011)
  • San Carlos, CA (US) (2013)
  • San Jose, CA (US) (1998 - 2024)

Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Fluorescence Detection
Nucleic Acids
Genomic Hybridization
SNP Analysis
Microarrays
Data Extraction
Sequencing Libraries
Signal-to-Noise Improvement
Optical Imaging
Biological Assays
DNA Fragmentation
Oligonucleotide Arrays
41 patents (USPTO):Explore Patents

Title: Nicholas Michael Sampas: Pioneering Inventor from San Jose

Introduction: Nicholas Michael Sampas is a renowned inventor based in San Jose, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Nicholas Michael Sampas holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Sampas has worked with leading tech companies in Silicon Valley, spearheading projects that have revolutionized the industry.

Collaborations: Throughout his career, Nicholas Michael Sampas has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his projects.

Conclusion: Nicholas Michael Sampas continues to inspire the next generation of inventors with his visionary ideas and relentless pursuit of technological advancement.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…